- Home
- ALT vs RNGR Comparison
ALT vs RNGR Comparison
Compare ALT & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | RNGR |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 347.1M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALT | RNGR |
|---|---|---|
| Price | $4.54 | $15.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $16.00 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 6.0M | 169.6K |
| Earning Date | 02-26-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 1.69% |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 0.66 |
| Revenue | $20,000.00 | ★ $547,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.56 |
| P/E Ratio | ★ N/A | $21.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $10.56 |
| 52 Week High | $7.73 | $18.45 |
Technical Indicators
Market Signals| Indicator | ALT | RNGR |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 59.89 |
| Support Level | $4.03 | $14.08 |
| Resistance Level | $4.40 | $15.29 |
| Average True Range (ATR) | 0.26 | 0.50 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 99.56 | 79.17 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.